60 Degrees Pharmaceuticals regains Nasdaq minimum bid price compliance

60 DEGREES PHARMACEUTICALS, INC.

Received Nasdaq notice on Aug 26, 2024 confirming compliance with Listing Rule 5550(a)(2).
Achieved closing bid price of $1.00+ for 10 consecutive trading days from Aug 12 to Aug 23, 2024.
Closing price on Aug 23, 2024 was $1.81 per share.
Company had been notified of non-compliance on Feb 27, 2024 for bid price below $1.00.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.